Osaic Holdings
PBLA

Osaic Holdings’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Osaic Holdings’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$63 – 7553
2023
Q4 		$63 Buy
+4
New +$63 ﹤0.01% 7149
2023
Q3 		– Hold
0
– – – 7372
2023
Q2 		– Hold
0
– – – 7433
2023
Q1 		– Hold
0
– – – 7401
2022
Q4 		– Hold
0
– – – 7768
2022
Q3 		– Hold
0
– – – 7186
2022
Q2 		– Hold
0
– – – 7000
2022
Q1 		– Hold
0
– – – 6368
2021
Q4 		– Hold
0
– – – 6710
2021
Q3 		– Hold
0
– – – 6423
2021
Q2 		– Hold
0
– -$1K – 7247
2021
Q1 		– Hold
0
– – – 6752

Osaic Holdings's PBLA Position: Q1 2024 in Review

Osaic Holdings sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q1 2024, closing a stake of 4 shares — an estimated $63 sold.

Osaic Holdings first reported a position in PBLA in Q4 2023 and held it in 1 quarter. The position peaked at $63 in Q4 2023. 0 funds tracked by Wall St. Rank hold PBLA as of Q1 2024.

  • Osaic Holdings reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 4 Panbela Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $63.
  • Osaic Holdings first reported a position in Panbela Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Osaic Holdings's Panbela Therapeutics, Inc. Common Stock position peaked at $63 in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.